Fibrosis in alcoholic and nonalcoholic steatohepatitis
- PMID: 21497741
- DOI: 10.1016/j.bpg.2011.02.010
Fibrosis in alcoholic and nonalcoholic steatohepatitis
Abstract
Both alcoholic and nonalcoholic steatohepatitis are relevant causes of cirrhosis and liver-related mortality. Alcohol abuse represents a major health problem in many countries, and liver disease is considered one of the most relevant causes of death related to this factor. Nonalcoholic fatty liver disease is the most common hepatic abnormality in the Western world, and progresses to cirrhosis and hepatocellular carcinoma in a significant portion of cases. Moreover, presence of NAFLD is associated with an increased risk of cardiovascular events. In this review, we discuss the characteristics of fibrosis in alcoholic and nonalcoholic steatohepatitis, focussing on the diagnostic issues and predictive factors. In addition, the pathogenetic mechanisms responsible for appearance and progression of fibrosis in the two conditions are briefly discussed.
Copyright © 2011. Published by Elsevier Ltd.
Similar articles
-
[Nonalcoholic and alcoholic steatohepatitis].Rev Med Chir Soc Med Nat Iasi. 2003 Jan-Mar;107(1):51-8. Rev Med Chir Soc Med Nat Iasi. 2003. PMID: 14755970 Review. Romanian.
-
Nonalcoholic steatohepatitis.Semin Liver Dis. 2004 Feb;24(1):3-20. doi: 10.1055/s-2004-823098. Semin Liver Dis. 2004. PMID: 15085483 Review.
-
Pathology of nonalcoholic fatty liver disease.Am J Clin Pathol. 2007 Nov;128(5):837-47. doi: 10.1309/RTPM1PY6YGBL2G2R. Am J Clin Pathol. 2007. PMID: 17951208 Review.
-
Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.Eur J Gastroenterol Hepatol. 2010 Jun;22(6):643-50. doi: 10.1097/MEG.0b013e32832ca0cb. Eur J Gastroenterol Hepatol. 2010. PMID: 19478676 Review.
-
Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.Liver Transpl. 2009 Dec;15(12):1843-51. doi: 10.1002/lt.21943. Liver Transpl. 2009. PMID: 19938117
Cited by
-
The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease.PLoS One. 2012;7(4):e35612. doi: 10.1371/journal.pone.0035612. Epub 2012 Apr 18. PLoS One. 2012. PMID: 22530059 Free PMC article.
-
New treatment options for alcoholic hepatitis.World J Gastroenterol. 2016 Apr 21;22(15):3892-906. doi: 10.3748/wjg.v22.i15.3892. World J Gastroenterol. 2016. PMID: 27099434 Free PMC article. Review.
-
The emerging importance of immunophilins in fibrosis development.Mol Cell Biochem. 2023 Jun;478(6):1281-1291. doi: 10.1007/s11010-022-04591-1. Epub 2022 Oct 27. Mol Cell Biochem. 2023. PMID: 36302992 Free PMC article. Review.
-
Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis.Cells. 2019 Nov 8;8(11):1409. doi: 10.3390/cells8111409. Cells. 2019. PMID: 31717385 Free PMC article.
-
Nonalcoholic Fatty Liver Disease: Correlation of the Liver Parenchyma Fatty Acid with Intravoxel Incoherent Motion MR Imaging-An Experimental Study in a Rat Model.PLoS One. 2015 Oct 13;10(10):e0139874. doi: 10.1371/journal.pone.0139874. eCollection 2015. PLoS One. 2015. PMID: 26460614 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical